Clinical outcomes of lung transplant recipients with pre-transplant Mycobacterium avium complex infection.
Sonya M KothadiaEric E CoberChristine E KovalJem M GolbinSusan HarringtonCyndee MirandaLauryn A BenningerJona M BanzonPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2024)
The bilateral LTR in our cohort did not develop MAC-PD despite not receiving MAC treatment post-transplant. It is possible source control was achieved with native lung explantation. Our observations suggest patients may not uniformly require pre- or post-transplant MAC treatment if they are smear-negative and undergo bilateral LT.